Literature DB >> 2481219

Peptide vaccines based on enhanced immunogenicity of peptide epitopes presented with T-cell determinants or hepatitis B core protein.

M J Francis, B E Clarke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2481219     DOI： 10.1016/0076-6879(89)78044-7

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  4 in total

1.  Immunological properties of hepatitis B core antigen fusion proteins.

Authors:  M J Francis; G Z Hastings; A L Brown; K G Grace; D J Rowlands; F Brown; B E Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

2.  Modified-live infectious bovine rhinotracheitis virus vaccine expressing monomer and dimer forms of foot-and-mouth disease capsid protein epitopes on surface of hybrid virus particles.

Authors:  S Kit; M Kit; R D DiMarchi; S P Little; C Gale
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

3.  Immunological evaluation of the multiple antigen peptide (MAP) system using the major immunogenic site of foot-and-mouth disease virus.

Authors:  M J Francis; G Z Hastings; F Brown; J McDermed; Y A Lu; J P Tam
Journal:  Immunology       Date:  1991-07       Impact factor: 7.397

Review 4.  Recent Advances in Vaccine Technologies.

Authors:  Michael James Francis
Journal:  Vet Clin North Am Small Anim Pract       Date:  2017-12-06       Impact factor: 2.093
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.